Preoperative Opioids Before Adult Spinal Deformity Surgery Associated with Increased Reoperations and High Rates of Chronic Postoperative Opioid Use at 3-year Follow-up

Overview

Journal Spine Deform

Publisher Springer Nature

Date 2022 Jan 23

PMID 35066794

Authors

Andre M Samuel

Kyle W Morse

Yuri A Pompeu

Avani S Vaishnav

Catherine Himo Gang

Han Jo Kim

Sheeraz A Qureshi

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the association of preoperative opioid prescriptions with reoperations and postoperative opioid prescriptions after adult spina deformity (ASD) surgery. With the current opioid crisis, patients undergoing surgery for ASD are at particular risk for opioid-related complications due to significant preoperative disability and surgical morbidity. No previous studies consider preoperative opioids in this population.

Methods: A retrospective cohort study of patients undergoing posterior spinal fusion (7 or more levels) for ASD was performed. All patients had at least 3 years of postoperative follow-up 3 years postoperatively. Prescriptions for 4 different opioid medications (hydromorphone, oxycodone, hydrocodone, and tramadol) were identified within 3 months preoperatively and up to 3 years postoperatively. Multivariate regression was utilized to determine the association of preoperative use with reoperations and with postoperative opioid use, controlling for both patient and surgery-related confounding factors.

Results: A total of 743 patients were identified and 59.6% (443) had opioid prescriptions within 3 months preoperatively. Postoperative opioid prescriptions were identified in 66.9% of patients at 12 months postoperatively, and in 54.8% at 36 months postoperatively. The 3-year reoperation rate was 11.0% in patients without preoperative prescriptions, 16.0% in patients with preoperative any opioid prescriptions (P = 0.07), and 34.8% in patients with preoperative hydromorphone prescriptions (P < 0.01). In multivariate analysis, preoperative opioid prescriptions were associated with increased reoperations (odds ratio [OR]: 1.62, P = 0.04), and chronic postoperative opioid use (OR: 4.40, P < 0.01). Preoperative hydromorphone prescriptions had the strongest association with both reoperations (OR: 4.96; P < 0.01) and chronic use (OR: 5.19: P = 0.03).

Conclusion: In the ASD population, preoperative opioids are associated with both reoperations and chronic opioid use, with hydromorphone having the strongest association. Further investigation of the benefits of preoperative weaning programs is warranted.

Citing Articles

Association Between Patient Reported Outcomes Measurement Information System Physical Function With Postoperative Pain, Narcotics Consumption, and Patient-Reported Outcome Measures Following Lumbar Microdiscectomy.

Bovonratwet P, Vaishnav A, Mok J, Urakawa H, Dupont M, Melissaridou D Global Spine J. 2022; 14(1):225-234.

PMID: 35623628 PMC: 10676173. DOI: 10.1177/21925682221103497.

References

Kelly M, Anderson P, Sasso R, Riew K . Preoperative opioid strength may not affect outcomes of anterior cervical procedures: a post hoc analysis of 2 prospective, randomized trials. J Neurosurg Spine. 2015; 23(4):484-9. PMC: 4701382. DOI: 10.3171/2015.1.SPINE14985. View

Hassanzadeh H, Jain A, El Dafrawy M, Ain M, Mesfin A, Skolasky R . Three-column osteotomies in the treatment of spinal deformity in adult patients 60 years old and older: outcome and complications. Spine (Phila Pa 1976). 2012; 38(9):726-31. DOI: 10.1097/BRS.0b013e31827c2415. View

Jain N, Himed K, Toth J, Briley K, Phillips F, Khan S . Opioids delay healing of spinal fusion: a rabbit posterolateral lumbar fusion model. Spine J. 2018; 18(9):1659-1668. DOI: 10.1016/j.spinee.2018.04.012. View

Pitter F, Sikora M, Lindberg-Larsen M, Pedersen A, Dahl B, Gehrchen M . Use of Opioids and Other Analgesics Before and After Primary Surgery for Adult Spinal Deformity: A 10-Year Nationwide Study. Neurospine. 2019; 17(1):237-245. PMC: 7136115. DOI: 10.14245/ns.1938106.053. View

Jain N, Brock J, Phillips F, Weaver T, Khan S . Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion. Spine J. 2018; 18(11):1989-1998. DOI: 10.1016/j.spinee.2018.03.015. View

Dunn L, Yerra S, Fang S, Hanak M, Leibowitz M, Tsang S . Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome. Anesth Analg. 2018; 127(1):247-254. PMC: 6487073. DOI: 10.1213/ANE.0000000000003338. View

La Maida G, Luceri F, Gallozzi F, Ferraro M, Bernardo M . Complication rate in adult deformity surgical treatment: safety of the posterior osteotomies. Eur Spine J. 2015; 24 Suppl 7:879-86. DOI: 10.1007/s00586-015-4275-5. View

Wilson N, Kariisa M, Seth P, Smith 4th H, Davis N . Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020; 69(11):290-297. PMC: 7739981. DOI: 10.15585/mmwr.mm6911a4. View

Lee D, Armaghani S, Archer K, Bible J, Shau D, Kay H . Preoperative Opioid Use as a Predictor of Adverse Postoperative Self-Reported Outcomes in Patients Undergoing Spine Surgery. J Bone Joint Surg Am. 2014; 96(11):e89. DOI: 10.2106/JBJS.M.00865. View

10.

Suk S, Kim J, Kim W, Lee S, Chung E . Posterior vertebral column resection for severe spinal deformities. Spine (Phila Pa 1976). 2002; 27(21):2374-82. DOI: 10.1097/00007632-200211010-00012. View

11.

Anand N, Sardar Z, Simmonds A, Khandehroo B, Kahwaty S, Baron E . Thirty-Day Reoperation and Readmission Rates After Correction of Adult Spinal Deformity via Circumferential Minimally Invasive Surgery-Analysis of a 7-Year Experience. Spine Deform. 2016; 4(1):78-83. DOI: 10.1016/j.jspd.2015.08.002. View

12.

Sharma M, Ugiliweneza B, SirDeshpande P, Wang D, Boakye M . Opioid Dependence and Health Care Utilization After Decompression and Fusion in Patients With Adult Degenerative Scoliosis. Spine (Phila Pa 1976). 2018; 44(4):280-290. DOI: 10.1097/BRS.0000000000002794. View

13.

Wang M, Lozen A, Laud P, Nattinger A, Krebs E . Factors associated with chronic opioid use after cervical spine surgery for degenerative conditions. J Neurosurg Spine. 2019; 32(1):1-8. DOI: 10.3171/2019.7.SPINE19563. View

14.

Kalakoti P, Volkmar A, Bedard N, Eisenberg J, Hendrickson N, Pugely A . Preoperative Chronic Opioid Therapy Negatively Impacts Long-term Outcomes Following Cervical Fusion Surgery. Spine (Phila Pa 1976). 2019; 44(18):1279-1286. DOI: 10.1097/BRS.0000000000003064. View

15.

Hills J, Pennings J, Archer K, Wick J, Daryoush J, Butler M . Preoperative Opioids and 1-year Patient-reported Outcomes After Spine Surgery. Spine (Phila Pa 1976). 2019; 44(12):887-895. DOI: 10.1097/BRS.0000000000002964. View

16.

Mazer-Amirshahi M, Ladkany D, Mullins P, Motov S, Perrone J, Nelson L . Trends in and predictors of hydromorphone administration in US emergency departments (2007-2014). J Opioid Manag. 2018; 14(4):265-272. DOI: 10.5055/jom.2018.0458. View

17.

Okie S . A flood of opioids, a rising tide of deaths. N Engl J Med. 2010; 363(21):1981-5. DOI: 10.1056/NEJMp1011512. View

18.

Li Z, Shen J, Qiu G, Yu H, Wang Y, Zhang J . Unplanned reoperation within 30 days of fusion surgery for spinal deformity. PLoS One. 2014; 9(3):e87172. PMC: 3942308. DOI: 10.1371/journal.pone.0087172. View

19.

Bess S, Line B, Fu K, McCarthy I, Lafage V, Schwab F . The Health Impact of Symptomatic Adult Spinal Deformity: Comparison of Deformity Types to United States Population Norms and Chronic Diseases. Spine (Phila Pa 1976). 2015; 41(3):224-33. PMC: 4718181. DOI: 10.1097/BRS.0000000000001202. View

20.

Auerbach J, Lenke L, Bridwell K, Sehn J, Milby A, Bumpass D . Major complications and comparison between 3-column osteotomy techniques in 105 consecutive spinal deformity procedures. Spine (Phila Pa 1976). 2012; 37(14):1198-210. DOI: 10.1097/BRS.0b013e31824fffde. View